Search Results - "Hannisdal, Einar"

Mediators of change in healthcare organisations subject to external assessment: a systematic review with narrative synthesis by Hovlid, Einar, Braut, Geir Sverre, Hannisdal, Einar, Walshe, Kieran, Bukve, Oddbjørn, Flottorp, Signe, Stensland, Per, Frich, Jan C

“…ObjectivesExternal inspections are widely used to improve the quality of care. The effects of inspections remain unclear and little is known about how they may…”
Get full text

Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years’ Follow-Up by SUNDSTRØM, Stein, BREMNES, Roy M, SKOVLUND, Eva, HANNISDAL, Einar, AAMDAL, Steinar, KAASA, Stein, AASEBØ, Ulf, HATLEVOLL, Reidulv, DAHLE, Ragnar, BOYE, Nils, WANG, Mari, VIGANDER, Tor, VILSVIK, Jan

“…To investigate whether chemotherapy with etoposide and cisplatin (EP) is superior to cyclophosphamide, epirubicin, and vincristine (CEV) in small-cell lung…”
Get full text

Next of Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part I – The Next of Kin’s Perspective) by Wiig, Siri, Haraldseid-Driftland, Cecilie, Tvete Zachrisen, Rannveig, Hannisdal, Einar, Schibevaag, Lene

“…OBJECTIVEThe aim of the study was to explore experiences from the next of kinʼs perspective of a new involvement method in the regulatory investigation process…”
Get full text

Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective) by Wiig, Siri, Schibevaag, Lene, Tvete Zachrisen, Rannveig, Hannisdal, Einar, Anderson, Janet E., Haraldseid-Driftland, Cecilie

“…OBJECTIVEThe aim of the study was to explore regulatory inspectorsʼ experiences with a new method for next-of-kin involvement in investigation of adverse…”
Get full text

Prognostic factors for glioblastoma multiforme--development of a prognostic index by Gundersen, S, Lote, K, Hannisdal, E

“…The prognosis for glioblastoma multiforme is generally poor. However, it can be useful to identify groups of patients with varying prognosis. Based on data…”
Get more information

Late medical sequelae after therapy for supradiaphragmatic Hodgkin's disease by Abrahamsen, A F, Loge, J H, Hannisdal, E, Nome, O, Lund, M B, Holte, H, Kvaløy, S

“…A total of 221 consecutive early stage Hodgkin's disease (HD) patients were given mantle field irradiation only or in combination with chemotherapy in…”
Get more information

A Risk Analysis of Cancer Care in Norway: The Top 16 Patient Safety Hazards by Hannisdal, Einar, Arianson, Helga, Braut, Geir Sverre, Schlichting, Ellen, Vinnem, Jan Erik

“…Cancer care processes represents a number of potential threats to patient safety. A national risk analysis of Norwegian cancer care, entailing diagnosis,…”
Get full text

Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers by Lopes, J M, Hannisdal, E, Bjerkehagen, B, Bruland, O S, Danielsen, H E, Pettersen, E O, Sobrinho-Simões, M, Nesland, J M

“…Controversy still exists regarding the validity of parameters commonly used in the evaluation of prognosis of patients with synovial sarcoma (SS). Forty-nine…”
Get full text

The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma : A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years by REED, W, HANNISDAL, E, BOEHLER, P. J, GUNDERSEN, S, HOST, H, NESLAND, J. M

“…Approximately 30% of breast carcinoma patients with negative lymph nodes die of their disease. Biologic markers such p53 protein and c-erb B-2 have been…”
Get full text

Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival by Saeter, G, Høie, J, Stenwig, A E, Johansson, A K, Hannisdal, E, Solheim, O P

“…A retrospective study of long term outcome after the development of metastases from osteosarcoma was performed, with emphasis on the impact of different…”
Get more information

Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients by REED, W, FLØRENES, V. A, HOLM, R, HANNISDAL, E, NESLAND, J. M

“…The search for better prognostic indicators and new treatment modalities in node-negative breast carcinoma patients is important. The aim of this study was to…”
Get full text

Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age by Abrahamsen, J F, Andersen, A, Hannisdal, E, Nome, O, Abrahamsen, A F, Kvaløy, S, Høst, H

“…In the period 1968 through 1988, The Norwegian Radium Hospital (NRH) treated an unselected population of 1,152 patients with Hodgkin's disease (HD) that…”
Get more information

A 10-year experience with splenectomy in patients with malignant non-Hodgkin's lymphoma at the Norwegian Radium Hospital by Lehne, G, Hannisdal, E, Langholm, R, Nome, O

“…Splenectomy is a major surgical intervention that has many implications for patients with malignant non-Hodgkin's lymphoma. As debated during the last few…”
Get more information

Skin treatment with bepanthen cream versus no cream during radiotherapy--a randomized controlled trial by Løkkevik, E, Skovlund, E, Reitan, J B, Hannisdal, E, Tanum, G

“…In several radiotherapy departments, dexpanthenol cream (Bepanthen 'Roche') has been used extensively to ameliorate acute radiotherapy skin reactions. The…”
Get more information

The prognostic value of p53 and c‐erb b‐2 immunostaining is overrated for patients with lymph node negative breast carcinoma by Reed, Wenche, Hannisdal, Einar, Boehler, Per Johannes, Gundersen, Stein, Host, Herman, Nesland, Jahn Marthin

“…BACKGROUND Approximately 30% of breast carcinoma patients with negative lymph nodes die of their disease. Biologic markers such p53 protein and c‐erb B‐2 have…”
Get full text

Combined Intra-arterial and Systemic Chemotherapy for Recurrent Malignant Brain Tumors by Watne, Kjell, Hannisdal, Einar, Nome, Ole, Hager, Bjarne, Hirschberg, Henry

Get full text

Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma by Wibe, E, Hannisdal, E, Paus, E, Aamdal, S

“…Serum neuron-specific enolase (NSE) was measured in 63 patients with metastatic malignant melanoma. 20 patients (32%) had elevated serum NSE (> 10…”
Get more information

Regression analyses of prognostic factors in colorectal cancer by Hannisdal, E, Thorsen, G

“…In a follow-up study of 110 patients with colorectal cancer, age, sex, erythrocyte sedimentation rate (ESR), hemoglobin (Hb), leukocyte count, emergency…”
Get more information

Survival after curative treatment of muscle-invasive bladder cancer by Fossa, S D, Aass, N, Ous, S, Waehre, H, Ilner, K, Hannisdal, E

“…This retrospective study includes 534 patients who had curatively intended treatment for T2/T3/T4a bladder cancer at the Norwegian Radium Hospital during the…”
Get more information

Prognostic factors in malignant gliomas with special reference to intra-arterial chemotherapy by Watne, K, Hannisdal, E, Nome, O, Hager, B, Hirschberg, H

“…Survival was analyzed in 173 patients with malignant gliomas to study the importance of possible pretreatment prognostic factors. Seventy-nine of these…”
Get more information